Summit Therapeutics Price Chart
Summit Therapeutics Volume Chart
Summit Therapeutics Market Segments
After Hours
-0.02(-0.15%)
| Open | $13.02 |
|---|---|
| Close | $13.00 |
| Low | $13.00 |
| Low Change | -0.02 (-0.15%) |
| High | $13.19 |
| High Change | +0.17 (+1.28%) |
| Range | $0.19 |
| Volume | 676.551K |
| Dollar Volume | $8.80M |
Regular Trading Hours
-0.42(-3.13%)
| Open | $13.44 |
|---|---|
| Close | $13.02 |
| Low | $13.01 |
| Low Change | -0.43 (-3.20%) |
| High | $13.59 |
| High Change | +0.15 (+1.10%) |
| Range | $0.58 |
| Volume | 3.304M |
| Dollar Volume | $43.01M |
Premarket
+0.09(+0.67%)
| Open | $13.35 |
|---|---|
| Close | $13.44 |
| Low | $13.26 |
| Low Change | -0.09 (-0.67%) |
| High | $13.48 |
| High Change | +0.13 (+0.97%) |
| Range | $0.22 |
| Volume | 10.832K |
| Dollar Volume | $145.58K |
Overnight
-0.05(-0.37%)
| Open | $13.35 |
|---|---|
| Close | $13.30 |
| Low | $13.26 |
| Low Change | -0.09 (-0.67%) |
| High | $13.35 |
| High Change | +0.00 (+0.00%) |
| Range | $0.09 |
| Volume | 586 |
| Dollar Volume | $7.79K |
After Hours Yesterday
-0.05(-0.34%)
| Open | $13.44 |
|---|---|
| Close | $13.39 |
| Low | $13.10 |
| Low Change | -0.34 (-2.50%) |
| High | $13.48 |
| High Change | +0.04 (+0.28%) |
| Range | $0.37 |
| Volume | 952.756K |
| Dollar Volume | $12.76M |
Regular Trading Hours Yesterday
+0.66(+5.16%)
| Open | $12.79 |
|---|---|
| Close | $13.45 |
| Low | $12.72 |
| Low Change | -0.07 (-0.55%) |
| High | $13.56 |
| High Change | +0.77 (+6.02%) |
| Range | $0.84 |
| Volume | 2.845M |
| Dollar Volume | $38.26M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $12.75 |
|---|---|
| Close | $12.75 |
| Low | $12.73 |
| Low Change | -0.02 (-0.16%) |
| High | $12.85 |
| High Change | +0.10 (+0.78%) |
| Range | $0.12 |
| Volume | 15.686K |
| Dollar Volume | $200.00K |
Summit Therapeutics News
1 week agoinvesting.comSummit Therapeutics stock rises on positive cancer trial data
2 months agoinvesting.comSummit Therapeutics stock rises after CEO share purchase
2 months agoinvesting.comSummit Therapeutics stock tumbles on $500M stock offering
2 months agoinvesting.comWhy is Summit Therapeutics stock sliding today?
6 months agoinvesting.comSummit Therapeutics stock rises after FDA accepts BLA for lung cancer drug
Summit Therapeutics Top Trades
Summit Therapeutics's top trade so far today returned +2.47%, while the top short trade returned -4.32%.
Summit Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $13.11 |
|---|---|
| 10 Day Moving Average (SMA10) | $13.72 |
| 20 Day Moving Average (SMA20) | $14.53 |
| 50 Day Moving Average (SMA50) | $14.83 |
| 100 Day Moving Average (SMA100) | $16.82 |
| 200 Day Moving Average (SMA200) | $17.10 |
Summit Therapeutics Statistics
| Average Volume (30 Days) | 4.56M |
|---|---|
| P/E Ratio (Current) | -11.96 |
| EPS (Current) | -$1.07 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$459.82M |
| Cash Ratio | 4.05 |
| Current Ratio | 6.95 |
| Quick Ratio | 6.95 |
| Debt to Equity | 0.00 |
| Enterprise Value | $9.79B |
| EV to EBITDA | -11.19 |
| EV to Sales | — |
| Price to Book | 16.21 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.14% |
| Return on Equity | -1.36% |
Summit Therapeutics Stock Splits
There have been no stock splits for Summit Therapeutics (SMMT).
Summit Therapeutics Dividends
There have been no dividends for Summit Therapeutics (SMMT).